Pulmonary vascular disease & thromboembolism

Multiparametric Contrast-Free MRI Successfully Identifies Venous Thrombus Responsive to Lytic Therapy: From Mice to Humans

Circ Cardiovasc ImagingPublished Diagnostic accuracy study

Authors' conclusion

MSTI enables noninvasive, contrast-free characterization of thrombus composition and predicts thrombolytic susceptibility.

Study context

Population
BALB/C mice with induced IVC venous thrombosis (systemic thrombolysis) and patients with acute iliofemoral DVT undergoing catheter-directed thrombolysis56 mice
Comparison
Lysed vs nonlysable thrombi on multisequence thrombus imaging
Outcome
Prelysis MSTI parameters (T1, ADC, magnetization transfer) of lysed vs nonlysable thrombi
Methodological detailstranslational (mice and humans), contrast-free
  • Translational (mice and humans)
  • Contrast-free

Performance

As reported in the abstract

Test or modelT1 (mice)ADC (mice)
Lysed723 [667-782] ms1.02 [0.96-1.14] ×10-³ mm²/s
Nonlysable874 [799-1000] ms0.78 [0.62-0.88] ×10-³ mm²/s

T1 (mice)

Lysed723 [667-782] ms
Nonlysable874 [799-1000] ms

ADC (mice)

Lysed1.02 [0.96-1.14] ×10-³ mm²/s
Nonlysable0.78 [0.62-0.88] ×10-³ mm²/s
  • Lysed vs Nonlysable: P < 0.001 — mice, T1: 723 [667-782] versus 874 [799-1000] ms
  • Lysed vs Nonlysable: P < 0.001 — mice, ADC: 1.02 [0.96-1.14] versus 0.78 [0.62-0.88]
  • Lysed vs Nonlysable: P < 0.001 — patients, T1: 606 [543-656] versus 765 [630-909] ms
  • Lysed vs Nonlysable: P = 0.001 — patients, ADC: 0.67 [0.5-1.1] versus 1.23 [0.69-1.74]
Combined multisequence thrombus imaging (MSTI) parameters, mice: sensitivity / specificity
88% / 97%
Combined MSTI parameters, humans: sensitivity / specificity
86% / 91%

Original publication

Multiparametric Contrast-Free MRI Successfully Identifies Venous Thrombus Responsive to Lytic Therapy: From Mice to Humans. Circ Cardiovasc Imaging. Published 3 November 2025. doi:10.1161/circimaging.125.018175

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.